Search research articles
Contact Us
Filters
Showing results (1-10 of 219) with videos related to
Page
of 22
Sort By:
Journal of the National Cancer Institute
|
October 11, 2007
The evidence for prostate cancer risk loci at 8q24 grows stronger
Sharon A Savage, Mark H Greene
Cancer Prevention Research (Philadelphia, Pa.)
|
March 25, 2015
The fallopian tube: from back stage to center stage
Mark H Greene, Phuong L Mai
Journal of the National Cancer Institute
|
January 15, 2009
What have we learned from risk-reducing salpingo-oophorectomy?
Mark H Greene, Phuong L Mai
Nature Reviews. Urology
|
September 26, 2018
Familial TGCT: polygenic aetiology advanced
Mark H Greene, Ruth M Pfeiffer
Qualitative Health Research
|
August 29, 2012
Anticipatory loss and early mastectomy for young female BRCA1/2 mutation carriers
Lindsey M Hoskins, Mark H Greene
Muscle & Nerve
|
May 24, 2023
Cancer in myotonic dystrophy: A new discovery in an old disease
Shahinaz M Gadalla, Mark H Greene
Cancer Prevention Research (Philadelphia, Pa.)
|
March 5, 2011
Challenges related to developing serum-based biomarkers for early ovarian cancer detection
Phuong L Mai, Nicolas Wentzensen, Mark H Greene
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2008
The importance of test positive predictive value in ovarian cancer screening
Mark H Greene, Ziding Feng, Mitchell H Gail
Urologic Oncology
|
June 20, 2008
Familial and genetic risk of transitional cell carcinoma of the urinary tract
Christine M Mueller, Neil Caporaso, Mark H Greene
American Journal of Obstetrics and Gynecology
|
July 13, 2010
Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?
Mark H Greene, Phuong L Mai, Peter E Schwartz
Page
of 22
Search research articles
Search
Showing results (1-10 of 219) with videos related to
Sort By:
Page
of 22
Journal of the National Cancer Institute
|
October 11, 2007
The evidence for prostate cancer risk loci at 8q24 grows stronger
Sharon A Savage, Mark H Greene
Cancer Prevention Research (Philadelphia, Pa.)
|
March 25, 2015
The fallopian tube: from back stage to center stage
Mark H Greene, Phuong L Mai
Journal of the National Cancer Institute
|
January 15, 2009
What have we learned from risk-reducing salpingo-oophorectomy?
Mark H Greene, Phuong L Mai
Nature Reviews. Urology
|
September 26, 2018
Familial TGCT: polygenic aetiology advanced
Mark H Greene, Ruth M Pfeiffer
Qualitative Health Research
|
August 29, 2012
Anticipatory loss and early mastectomy for young female BRCA1/2 mutation carriers
Lindsey M Hoskins, Mark H Greene
Muscle & Nerve
|
May 24, 2023
Cancer in myotonic dystrophy: A new discovery in an old disease
Shahinaz M Gadalla, Mark H Greene
Cancer Prevention Research (Philadelphia, Pa.)
|
March 5, 2011
Challenges related to developing serum-based biomarkers for early ovarian cancer detection
Phuong L Mai, Nicolas Wentzensen, Mark H Greene
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2008
The importance of test positive predictive value in ovarian cancer screening
Mark H Greene, Ziding Feng, Mitchell H Gail
Urologic Oncology
|
June 20, 2008
Familial and genetic risk of transitional cell carcinoma of the urinary tract
Christine M Mueller, Neil Caporaso, Mark H Greene
American Journal of Obstetrics and Gynecology
|
July 13, 2010
Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?
Mark H Greene, Phuong L Mai, Peter E Schwartz
Page
of 22